LONDON--(BUSINESS WIRE)--Jul 30, 2018--According to the latest market research report released by Technavio, the global genetic testing market is expected to accelerate at a CAGR of more than 10% during the forecast period. The increasing prevalence of genetic disorders is one of the key factors triggering the growth of the market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180730005428/en/

Technavio has published a new market research report on the global genetic testing market from 2018-2022. (Graphic: Business Wire)

This research report titled ‘ ’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. It also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.

This report is available at a USD 1,000 discount for a limited time only:

The market research analysis categorizes the global genetic testing market into the following products:

Analyzers Consumables

In 2017, the consumables segment accounted for 70% share of the global market and is projected to increase to 75% by 2022. The growth can be attributed to the increased and repetitive use of consumables to conduct genetic tests. End-users such as clinical diagnostics laboratories and hospitals are increasingly demanding for consumables to perform genetic tests on individuals requiring genetic testing.

Global genetic testing market: Top emerging trend

Growing demand for companion diagnostics is an emerging trend in the genetic testing market. According to NIH, genetic variations can lead to different responses to the same medication from different people, which increased the demand for pharmacogenomics. Hence, there are several companion diagnostics available in the market. To conduct tests in order to develop personalized medicine, biomarkers are used to identify the gene linked to the failure of such pharmaceutical products. To develop such products, genetic testing product manufacturers and pharmaceutical companies are collaborating. In the Americas and Europe, the demand and sales of companion diagnostic products are increasing, which has upsurged the number of companion diagnostic products in these regions. Besides this, several vendors in the market are also focusing on developing companion diagnostic tests for cancer and autoimmune diseases.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Technavio’s report provides expert market research on the following topics:

Executive Report

Market Outline Global Genetic Testing Market Overview

Market Insights

Market Sizing and Forecasts Market Growth Market Drivers and Challenges Key Emerging Trends

Market Segmentation Analysis

Regional comparison (APAC, Americas, and EMEA) Market segmentation by product (analyzers and consumables)

Vendor Landscape

Vendor classification Market positioning of vendors Competitive scenario Analysis of top vendors (Abbott, bioMérieux, Bio-Rad Laboratories, F. Hoffmann-La Roche, Myriad Genetics, QIAGEN, and Quest Diagnostics)

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180730005428/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS PHARMACEUTICAL

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 07/30/2018 09:59 AM/DISC: 07/30/2018 09:59 AM

http://www.businesswire.com/news/home/20180730005428/en